These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29074400)

  • 1. Paternal use of thiopurines and methotrexate: Are we reassured enough?
    Simsek M; de Boer NKH
    Reprod Toxicol; 2018 Jan; 75():146. PubMed ID: 29074400
    [No Abstract]   [Full Text] [Related]  

  • 2. Paternal use of azathioprine/6-mercaptopurine or methotrexate within 3 months before conception and long-term health outcomes in the offspring-A nationwide cohort study.
    Friedman S; Larsen MD; Magnussen B; Jølving LR; de Silva P; Nørgård BM
    Reprod Toxicol; 2017 Oct; 73():196-200. PubMed ID: 28844800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of congenital abnormalities in children fathered by men treated with azathioprine or mercaptopurine before conception.
    Nørgård B; Pedersen L; Jacobsen J; Rasmussen SN; Sørensen HT
    Aliment Pharmacol Ther; 2004 Mar; 19(6):679-85. PubMed ID: 15023170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reassuring results on birth outcomes in children fathered by men treated with azathioprine/6-mercaptopurine within 3 months before conception: a nationwide cohort study.
    Nørgård BM; Magnussen B; Larsen MD; Friedman S
    Gut; 2017 Oct; 66(10):1761-1766. PubMed ID: 27456154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine.
    Wahed M; Louis-Auguste JR; Baxter LM; Limdi JK; McCartney SA; Lindsay JO; Bloom SL
    Aliment Pharmacol Ther; 2009 Sep; 30(6):614-20. PubMed ID: 19552632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn's disease.
    Kariyawasam VC; Selinger CP; Katelaris PH; Jones DB; McDonald C; Barr G; Chapman G; Colliwshaw J; Lunney PC; Middleton K; Wang RR; Huang T; Andrews J; Leong RW
    Inflamm Bowel Dis; 2014 Aug; 20(8):1382-90. PubMed ID: 24991785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
    Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
    Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate for Refractory Crohn's Disease Compared with Thiopurines: A Retrospective Non-head-to-head Controlled Study.
    Huang Z; Chao K; Li M; Zhi M; Tang J; Hu P; Gao X
    Inflamm Bowel Dis; 2017 Mar; 23(3):440-447. PubMed ID: 28129286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of thiopurines as disease-modifying agents in Crohn's disease.
    Blackwell J; Saxena S; Pollok RC
    Gut; 2018 Dec; 67(12):2229-2230. PubMed ID: 29298871
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: thiopurines - is less really more?
    Meijer B; de Boer NKH
    Aliment Pharmacol Ther; 2018 Jan; 47(1):149. PubMed ID: 29226406
    [No Abstract]   [Full Text] [Related]  

  • 12. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic role of methotrexate in pediatric Crohn's disease.
    Djurić Z; Šaranac L; Budić I; Pavlović V; Djordjević J
    Bosn J Basic Med Sci; 2018 Aug; 18(3):211-216. PubMed ID: 29338679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate.
    Sandborn WJ
    Am J Gastroenterol; 1996 Mar; 91(3):423-33. PubMed ID: 8633486
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical use of immunosuppressive drugs: part II.
    Gerber NL; Steinberg AD
    Drugs; 1976; 11(2):90-112. PubMed ID: 1278059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enduring Value of Thiopurines for Inflammatory Bowel Disease Therapy.
    Korelitz BI
    Dig Dis Sci; 2017 Feb; 62(2):292-293. PubMed ID: 28025747
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.
    Kotlyar DS; Lewis JD; Beaugerie L; Tierney A; Brensinger CM; Gisbert JP; Loftus EV; Peyrin-Biroulet L; Blonski WC; Van Domselaar M; Chaparro M; Sandilya S; Bewtra M; Beigel F; Biancone L; Lichtenstein GR
    Clin Gastroenterol Hepatol; 2015 May; 13(5):847-58.e4; quiz e48-50. PubMed ID: 24879926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy outcome after paternal exposure to azathioprine/6-mercaptopurine.
    Hoeltzenbein M; Weber-Schoendorfer C; Borisch C; Allignol A; Meister R; Schaefer C
    Reprod Toxicol; 2012 Nov; 34(3):364-9. PubMed ID: 22609326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can we get more from our current treatments?
    Irving PM
    Best Pract Res Clin Gastroenterol; 2014 Jun; 28(3):451-63. PubMed ID: 24913384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate: first-line or second-line immunomodulator?
    Fraser AG
    Eur J Gastroenterol Hepatol; 2003 Mar; 15(3):225-31. PubMed ID: 12610315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.